Health Catalyst, Inc - Common stock (HCAT) Covered Calls
Health Catalyst, Inc. is a leading provider of data and analytics technology and services to healthcare organizations. The company proprietary cloud-based data platform, analytics software, and professional services help health systems manage data and derive insights to improve clinical, financial, and operational outcomes. By unifying data from disparate sources, it enables healthcare providers to transition toward value-based care and data-informed decision-making.
You can sell covered calls on Health Catalyst, Inc - Common stock to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for HCAT (prices last updated Mon 4:16 PM ET):
| Health Catalyst, Inc - Common stock (HCAT) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 1.91 | -0.04 | 0.74 | 2.09 | 496K | - | 0.1 |
| Covered Calls For Health Catalyst, Inc - Common stock (HCAT) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 2.5 | 0.00 | 2.09 | 0.0% | 0.0% | |
| Apr 17 | 2.5 | 0.00 | 2.09 | 0.0% | 0.0% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Health Catalyst, Inc. operates at the center of the digital transformation in healthcare, providing an ecosystem of data warehousing and analytics solutions. The company flagship "Health Catalyst Ignite" platform serves as a central hub, integrating data from hundreds of sources—including Electronic Health Records (EHRs) and claims data—to provide a single source of truth for hospital executives. Its business model is bifurcated into Technology (recurring subscriptions) and Professional Services (strategic advisory and outsourcing).
In early 2026, the company underwent a significant leadership transition with the appointment of Ben Albert as Chief Executive Officer. Under this new leadership, the company has pivoted toward a "client-centric" migration strategy, helping legacy customers transition to the modular Ignite platform while maintaining support for older systems. Despite facing headwinds from dollar-based retention rates in the low 90s during late 2025, the company has achieved positive free cash flow and is focusing on expanding its high-margin technology recurring revenue through AI-enabled population health and cost-accounting tools.
Competition
The company competes in the rapidly evolving healthcare information technology (HCIT) and data analytics market. Its primary rivals in the enterprise data and specialized healthcare analytics space include Veeva Systems and HealthStream. These firms compete for market share in providing cloud-based infrastructure and workforce development tools specifically tailored to the medical sector.
Additionally, the company faces indirect competition from diversified software and communications providers that offer specialized healthcare verticals, such as Docebo and Bandwidth. In the broader analytics and decisioning space, it contends with firms like Cognyte Software. Competition is driven by the depth of healthcare-specific data models, the ability to integrate with legacy EHR systems, and the proven return on investment (ROI) that the platforms provide to financially strained health systems.
Strategic Outlook
The strategic outlook for the company through 2026 is focused on achieving consistent adjusted EBITDA growth and stabilizing its net new client acquisition. Management has adopted a measured approach to 2026 guidance, prioritizing "underwriting discipline" in its professional services contracts and exiting lower-margin pilot programs. A key priority is the integration of its recent acquisition of Upfront, which enhances the company patient engagement and orchestration capabilities, allowing for a more comprehensive end-to-end data solution.
Future innovation efforts are centered on the deployment of "Modular AI" solutions that automate clinical documentation and identify revenue cycle leaks in real-time. The company is also exploring expansion into international markets and adjacent sectors like life sciences to diversify its revenue streams. By maintaining a strong liquidity position and focusing on its core mission of "massive, measurable improvement," the company aims to navigate the current cyclical challenges in hospital spending and emerge as the essential data layer for the next generation of value-based healthcare.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PATH covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | KSS covered calls | |
| 4. | SPY covered calls | 9. | FXI covered calls | 4. | OWL covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | USO covered calls | |
Want more examples? HCA Covered Calls | HCC Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
